Interaction Between Adipose Tissue-Derived Mesenchymal Stem Cells and Regulatory T-Cells

被引:51
作者
Engela, Anja U. [1 ]
Baan, Carla C. [1 ]
Peeters, Annemiek M. A. [1 ]
Weimar, Willem [1 ]
Hoogduijn, Martin J. [1 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Internal Med, Transplantat Lab Nephrol, Rotterdam, Netherlands
关键词
Mesenchymal stem cells (MSCs); Regulatory T-cells (Tregs); Immunosuppression; Transplantation; MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; KIDNEY-TRANSPLANT PATIENTS; LINKED SYNDROME IPEX; LYMPHOCYTE-PROLIFERATION; IN-VITRO; IMMUNOSUPPRESSIVE DRUGS; ORGAN-TRANSPLANTATION; IMMUNE DYSREGULATION; GENE-EXPRESSION;
D O I
10.3727/096368912X636984
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stem cells (MSCs) exhibit immunosuppressive capabilities, which have evoked interest in their application as cell therapy in transplant patients. So far it has been unclear whether allogeneic MSCs and host regulatory T-cells (Tregs) functionally influence each other. We investigated the interaction between both cell types using perirenal adipose tissue-derived MSCs (ASCs) from kidney donors and Tregs from blood bank donors or kidney recipients 6 months after transplantation. The immunomodulatory capacity of ASCs was not prejudiced by both Tregs from healthy donors and Tregs from graft recipients, indicating that ASCs were not targeted by the inhibitory effects of Tregs and vice versa. In addition, Tregs supported ASC function, as they did not alter the secretion of IFN-gamma by immune cells and hence contributed to ASC activation and efficiency. ASCs exerted their suppressive role by expressing IDO, reducing levels of TNF-alpha, and by inducing the production of IL-10 in effector cells and Tregs. In conclusion, this study presents evidence that donor ASCs and acceptor Tregs do not impair each other's function and therefore encourages the use of MSC therapy for the prevention of graft rejection in solid organ transplantation.
引用
收藏
页码:41 / 54
页数:14
相关论文
共 60 条
[1]   Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells [J].
Ando, Wataru ;
Tateishi, Kosuke ;
Hart, David A. ;
Katakai, Daisuke ;
Tanaka, Yoshinari ;
Nakata, Ken ;
Hashimoto, Jun ;
Fujie, Hiromichi ;
Shino, Konsel ;
Yoshikawa, Hideki ;
Nakamura, Norimasa .
BIOMATERIALS, 2007, 28 (36) :5462-5470
[2]   Amniotic Fluid as a Rich Source of Mesenchymal Stromal Cells for Transplantation Therapy [J].
Antonucci, Ivana ;
Stuppia, Liborio ;
Kaneko, Yuji ;
Yu, Seongjin ;
Tajiri, Naoki ;
Bae, Eunkyung C. ;
Chheda, Sonia H. ;
Weinbren, Nathan L. ;
Borlongant, Cesar V. .
CELL TRANSPLANTATION, 2011, 20 (06) :789-795
[3]   Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway [J].
Augello, A ;
Tasso, R ;
Negrini, SM ;
Amateis, A ;
Indiveri, F ;
Cancedda, R ;
Pennesi, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1482-1490
[4]   Defective regulatory and effector T cell functions in patients with FOXP3 mutations [J].
Bacchetta, Rosa ;
Passerini, Laura ;
Gambineri, Eleonora ;
Dai, Minyue ;
Allan, Sarah E. ;
Perroni, Lucia ;
Dagna-Bricarelli, Franca ;
Sartirana, Claudia ;
Matthes-Martins, Susanne ;
Lawitschka, Anita ;
Azzari, Chiara ;
Ziegler, Steven F. ;
Levings, Megan K. ;
Roncarolo, Maria Grazia .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (06) :1713-1722
[5]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[6]   Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves [J].
Batten, Puspa ;
Sarathchandra, Padmini ;
Antoniw, Joseph W. ;
Tay, Szun Szun ;
Lowdell, Mark W. ;
Taylor, Patricia M. ;
Yacoub, Magdi H. .
TISSUE ENGINEERING, 2006, 12 (08) :2263-2273
[7]   The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].
Bennett, CL ;
Christie, J ;
Ramsdell, F ;
Brunkow, ME ;
Ferguson, PJ ;
Whitesell, L ;
Kelly, TE ;
Saulsbury, FT ;
Chance, PF ;
Ochs, HD .
NATURE GENETICS, 2001, 27 (01) :20-21
[8]   Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates [J].
Bestard, Oriol ;
Cruzado, Josep M. ;
Mestre, Mariona ;
Caldes, Anna ;
Bas, Jordi ;
Carrera, Marta ;
Torras, Joan ;
Rama, Ines ;
Moreso, Francesc ;
Seron, Daniel ;
Grinyo, Josep M. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (07) :4901-4909
[9]   Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics [J].
Brunstein, Claudio G. ;
Miller, Jeffrey S. ;
Cao, Qing ;
McKenna, David H. ;
Hippen, Keli L. ;
Curtsinger, Julie ;
DeFor, Todd ;
Levine, Bruce L. ;
June, Carl H. ;
Rubinstein, Pablo ;
McGlave, Philip B. ;
Blazar, Bruce R. ;
Wagner, John E. .
BLOOD, 2011, 117 (03) :1061-1070
[10]  
Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO